logo
Doctors Say Injecting Gold Into Eyeballs Could Restore Lost Vision

Doctors Say Injecting Gold Into Eyeballs Could Restore Lost Vision

Yahoo26-04-2025
Gold, laser goggles, and a camera: it's an unlikely combination that could one day be used to restore vision in people with retinal damage, according to researchers.
In a new study published in the journal ACS Nano, the team found that injecting gold nanoparticles into the eyes of mice with retinal disorders helped stimulate the rodents' visual systems and bring back some vision.
When targeted with infrared lasers, the microscopic gold pieces reproduce electrical signals similar to those emitted by cells in the retina that are essential to eyesight but are damaged by conditions like macular degeneration, which affects some 20 million Americans.
"This is a new type of retinal prosthesis that has the potential to restore vision lost to retinal degeneration without requiring any kind of complicated surgery or genetic modification," lead author Jiarui Nie, a researcher at Brown University and the National Institutes of Health, said in a statement about the work. "We believe this technique could potentially transform treatment paradigms for retinal degenerative conditions."
The most common retinal disorder, age-related macular degeneration, involves damage to cells in the retina called photoreceptors, causing blurry vision, blind spots, and in advanced stages, total loss of central vision. These photoreceptors come in the form of "cone" cells responsible for our perception of color, and "rod" cells that handle low light conditions. When light falls on them, the cones and rods zap little electrical pulses that are sent to bipolar and ganglion cells, which process the signals before they're beamed to the brain. If the photoreceptors are damaged, however, then the entire visual chain is cut off.
But gold nanoparticles — specifically, plasmonic gold nanorods — could effectively replace them. In the mice experiments, the researchers found that focusing infrared light onto the metal particles generated heat that stimulated the bipolar and ganglion cells, just like the photoreceptors would. This resulted in increased activity in the visual cortices of the mices' brains, indicating that the visual signals were in fact being received and that their vision was partially restored. And so far, the team hasn't observed any side effects from the approach.
"We showed that the nanoparticles can stay in the retina for months with no major toxicity," Nie said.
Applied to humans, a pair of goggles would beam infrared lasers encoding image data gathered from an onboard camera into the gold nanoparticles, and eureka — you have visual signals being sent to the brain. A similar approach was proposed a few years ago, the team notes, but crucially, this one doesn't require surgery, just a relatively simple injection (and a very advanced piece of headgear).
Nie believes the approach has other advantages, too, like allowing for a far higher-resolution image with a complete field of vision. Promising as it is, though, there's still significant research to be done before it can be tried in a clinical setting on humans, Nie said.
More on eyes: Scientists Hack Human Eye to See a Whole New Color, Called "Olo"
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

What to know about Parkinson's disease after Ozzy Osbourne's death
What to know about Parkinson's disease after Ozzy Osbourne's death

Chicago Tribune

time22 minutes ago

  • Chicago Tribune

What to know about Parkinson's disease after Ozzy Osbourne's death

Heavy metal rocker Ozzy Osbourne died this week at 76, just weeks after his farewell show and about five years after announcing he had Parkinson's disease. Here's what to know about the disease: Parkinson's is a neurologic disease that robs people of control over their movements. It typically starts with tremors and is characterized by slow movement, a shuffling gait, stiff limbs, balance problems and slurred speech. About 1 million Americans are living with Parkinson's, and 10 million people worldwide, the Parkinson's Foundation estimates. It usually appears after age 60, although sometimes it can develop before age 50. The exact cause isn't known, but Parkinson's develops when cells that produce one of the brain's chemical messengers, called dopamine, begin to deteriorate and die. Dopamine transports signals to parts of the brain that control movement. Parkinson's symptoms appear after enough dopamine-producing cells die that there's too little of this neurotransmitter in the brain. According to the foundation, most experts believe genetic and environmental factors are behind the disease. Dozens of gene mutations linked to Parkinson's have been discovered and genetics account for 10% to 15% of all cases. Other factors suspected of increasing the risk include head injuries, exposure to pesticides and herbicides and where you live. Ozzy Osbourne, lead singer of Black Sabbath and godfather of heavy metal, dies at 76There is no cure but there are treatments, including medications that affect dopamine levels and a surgically implanted tremor-blocking device. Patients also can benefit from physical and occupational therapy. Symptoms worsen over time, usually slowly. The severity of symptoms and how quickly they progress varies widely between patients. In advanced cases, people may be unable to walk or care for themselves. They also can suffer from depression as well as memory and thinking problems. While Parkinson's itself isn't considered fatal, people can die from complications of the disease, including lung problems as muscle weakness impedes the ability to cough and to swallow.

U.S. to remove mercury preservative from flu shots following RFK Jr. vaccine panel vote
U.S. to remove mercury preservative from flu shots following RFK Jr. vaccine panel vote

CNBC

time23 minutes ago

  • CNBC

U.S. to remove mercury preservative from flu shots following RFK Jr. vaccine panel vote

The Department of Health and Human Services on Wednesday said it will officially remove the mercury-based preservative thimerosal from all flu shots distributed in the U.S. – even though there is no evidence of harm from the ingredient. While few jabs still contain thimerosal, the move eliminates a vaccine option for Americans and is a win for the anti-vaccine movement, which has long targeted the ingredient. HHS Secretary Robert F. Kennedy Jr. formally adopted a June recommendation from a key government vaccine panel, called the Advisory Committee on Immunization Practices, or ACIP, against influenza shots containing thimerosal. Earlier that month, Kennedy gutted that panel and restacked it with new members, including some widely known anti-vaccine activists. The decision affects roughly 4% to 5% of the U.S. flu vaccine supply. That includes some multi-dose forms of Sanofi's Fluzone and two shots from biotech company CSL Seqirus. The rest of the nation's flu shots were thimerosal-free during the last season of the virus, according to CDC data. Vaccine manufacturers have confirmed that they have the capacity to replace multi-dose vials containing mercury, HHS said. That will ensure that the flu vaccine for adults and a government program that provides shots to uninsured and underinsured children won't be interrupted, the agency added. Still, health experts have said that eliminating thimerosal-containing flu shots as an option for Americans could lead to fewer people receiving jabs. The move also reinforces longstanding, unfounded fears that the substance can lead to developmental disabilities, such as autism. Kennedy's vaccine skepticism comes full circle with ACIP's vote: A decade before stepping into his current role, he published a book that called for the removal of thimerosal from shots and linked it to developmental disorders. "After more than two decades of delay, this action fulfills a long-overdue promise to protect our most vulnerable populations from unnecessary mercury exposure," Kennedy said in a release, urging global health authorities to follow suit. More than 40 studies over several decades have found no link between thimerosal and developmental delays. Thimerosal has been widely used for decades as a preservative to prevent the growth of harmful bacteria in several medicines and vaccines with multiple doses. HHS said other recommendations from the panel's meeting in June are still under review.

Warnings Issues to Americans Traveling to Three Destinations
Warnings Issues to Americans Traveling to Three Destinations

Newsweek

timean hour ago

  • Newsweek

Warnings Issues to Americans Traveling to Three Destinations

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The Centers for Disease Control and Prevention (CDC) has issued two travel warnings, advising Americans to practice "enhanced precautions" when traveling to three countries. The CDC warned travelers of "confirmed and suspect cases" of diphtheria in the Kankan region of Guinea, as well as outbreaks of mpox in Liberia and Sierra Leone. "I would be most concerned about diphtheria," a medical expert told Newsweek in part. "Diphtheria was a major cause of morbidity and mortality in the past and especially in children under the age of 15 years of whom 5 to 10 percent died." The CDC, like the Department of State, releases travel warnings using a four-level system—with Level 1 indicating the lowest risk associated with the country, while Level 4 warns Americans not to go to a certain destination. Why It Matters Travel advisories highlight the need for Americans to stay aware and advised about the safety and health risks associated with countries when going abroad, particularly as diseases like mpox and diphtheria can spread rapidly and have significant health impacts if not properly managed. File photo: Monrovia, the capital city of Liberia, West Africa, seen from the top of the ruins of Hotel Ducor. File photo: Monrovia, the capital city of Liberia, West Africa, seen from the top of the ruins of Hotel Ducor. jbdodane/Getty Images What To Know Mpox, commonly known as Monkeypox, can be transmitted via close or intimate contact, including sexual activity, as well as from contaminated bedding, clothing, or dishware, and through contact with wild animals. Symptoms often include fever, rash, headache, muscle aches, and swollen lymph nodes. There is an available vaccine for the disease, which the CDC has advised certain Americans to have. The CDC recommends that all travelers engaging in activities such as new sexual partnerships, massages, commercial sex venues, or large gatherings consider the two-dose JYNNEOS vaccination for Mpox a few weeks before travel. In its advisory on Sierra Leone and Liberia, the CDC said that outbreaks of Clade II mpox, one of the two types of mpox, have been confirmed in both countries. The outbreaks have affected both males and females equally, contrasting the 2022 global spread that primarily impacted men who have sex with men. Travelers are also advised to avoid contact with those who appear symptomatic and to avoid bushmeat or wild animal exposure. Meanwhile, diphtheria is a bacterial infection that can cause severe respiratory problems and, if untreated, may be fatal in serious cases. It is transmitted via respiratory droplets, i.e. coughing and sneezing, and skin contact. For those planning on visiting Guinea, especially in the Kankan region, the CDC has advised travelers to ensure their diphtheria vaccination is current and to discuss booster shots with their healthcare providers. Travelers should also observe strict hygiene protocols, including frequent handwashing and avoiding individuals with symptoms such as sore throat, difficulty swallowing, or fever. The CDC also emphasized rapid action if either illness develops during or after travel. Those feeling unwell upon their return from any of the three countries are urged to seek immediate medical care and inform medical personnel about recent travel history and vaccination status. What People Are Saying Dr Philip Chan, a professor of medicine at Brown University, Rhode Island, told Newsweek: "It's concerning that we're seeing outbreaks of vaccine-preventable diseases in some of these countries. The good news is that they are preventable with currently available vaccines. For people traveling to affected countries, I would recommend discussing with a physician and making sure you are vaccinated against these infections. "I would be most concerned about diphtheria. Diphtheria was a major cause of morbidity and mortality in the past and especially in children under the age of 15 years of whom 5 to 10 percent died. It's important for adults who are traveling to affected countries to make sure they are up to date on their diphtheria booster because immunity does wane over time in many adults. In general, if people are up to date with vaccinations and take reasonable precautions, such as avoiding contact with sick people, washing your hands, and others, then I wouldn't worry as much." What Happens Next The CDC will continue to monitor outbreaks and update advisories for different countries over the course of the year. Americans considering travel to Sierra Leone, Liberia, or Guinea should consult the latest CDC and State Department recommendations prior to booking travel, and prepare accordingly.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store